Stoneham, MA, United States of America

Lizhi Cao

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Palleon Pharmaceuticals Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lizhi Cao. Retrieved from https://idiyas.com/inventor/lizhi-cao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lizhi Cao

Introduction

Lizhi Cao is an accomplished inventor based in Stoneham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant human sialidases. His work has the potential to impact cancer treatment methodologies.

Latest Patents

Cao holds a patent for "Recombinant human sialidases, sialidase fusion proteins, and methods of using the same." This invention relates to recombinant human sialidases and recombinant sialidase fusion proteins, which may contain mutations compared to wild-type human sialidase. The patent also includes antibody conjugates that combine a sialidase with an antibody or a portion thereof. Furthermore, it outlines methods for utilizing these sialidase fusion proteins or antibody conjugates in cancer treatment.

Career Highlights

Cao is currently associated with Palleon Pharmaceuticals Inc., where he continues to advance his research and innovations. His work at the company focuses on developing therapeutic solutions that leverage his expertise in sialidases.

Collaborations

Cao collaborates with notable colleagues, including Li Peng and Lihui Xu, who contribute to his research endeavors and the advancement of their shared goals in biotechnology.

Conclusion

Lizhi Cao's innovative work in recombinant human sialidases exemplifies the intersection of biotechnology and cancer treatment. His contributions are paving the way for new therapeutic approaches that could significantly benefit patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…